Daewoong Future Growth

Future criteria checks 0/6

Daewoong is forecast to grow revenue at 7.8% per annum.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth36.2%
Revenue growth rate7.8%
Future return on equityn/a
Analyst coverage

Low

Last updated27 Nov 2023

Recent future growth updates

No updates

Recent updates

Does Daewoong (KRX:003090) Have A Healthy Balance Sheet?

Apr 02
Does Daewoong (KRX:003090) Have A Healthy Balance Sheet?

With EPS Growth And More, Daewoong (KRX:003090) Is Interesting

Apr 13
With EPS Growth And More, Daewoong (KRX:003090) Is Interesting

A Look At The Intrinsic Value Of Daewoong Co., Ltd. (KRX:003090)

Mar 29
A Look At The Intrinsic Value Of Daewoong Co., Ltd. (KRX:003090)

Daewoong Co., Ltd. (KRX:003090) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Mar 14
Daewoong Co., Ltd. (KRX:003090) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Daewoong (KRX:003090) Seems To Use Debt Quite Sensibly

Feb 21
Daewoong (KRX:003090) Seems To Use Debt Quite Sensibly

The Daewoong (KRX:003090) Share Price Has Soared 308%, Delighting Many Shareholders

Jan 31
The Daewoong (KRX:003090) Share Price Has Soared 308%, Delighting Many Shareholders

Do Its Financials Have Any Role To Play In Driving Daewoong Co., Ltd.'s (KRX:003090) Stock Up Recently?

Dec 04
Do Its Financials Have Any Role To Play In Driving Daewoong Co., Ltd.'s (KRX:003090) Stock Up Recently?

Earnings and Revenue Growth Forecasts

KOSE:A003090 - Analysts future estimates and past financials data (KRW Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20252,082,100N/A87,100257,7001
12/31/20241,882,600N/A49,500211,3001
3/31/20241,821,844135,340-33,830218,599N/A
12/31/20231,813,841152,665-22,490205,655N/A
9/30/20231,811,723123,04968,111228,147N/A
6/30/20231,783,012122,64752,987191,958N/A
3/31/20231,735,656117,54711,157145,438N/A
12/31/20221,697,338102,56632,788149,082N/A
9/30/20221,657,478124,723392132,746N/A
6/30/20221,600,944112,64636,629149,775N/A
3/31/20221,560,37799,01826,202151,077N/A
12/31/20211,511,37478,73017,866133,175N/A
9/30/20211,451,197105,59335,115115,866N/A
6/30/20211,428,06894,02438,115123,389N/A
3/31/20211,375,58186,02851,902118,843N/A
12/31/20201,355,33798,37982,383145,366N/A
9/30/20201,362,72949,53147,566109,128N/A
6/30/20201,343,95745,56942,613111,926N/A
3/31/20201,375,38465,05855,589128,422N/A
12/31/20191,365,67961,49357,736138,512N/A
9/30/20191,339,50241,771107,061176,956N/A
6/30/20191,313,89844,53062,728135,359N/A
3/31/20191,261,87927,35511,99180,623N/A
12/31/20181,231,29029,863-24,93045,381N/A
9/30/20181,186,05968,3594,31380,421N/A
6/30/20181,171,37268,406-9,62183,812N/A
3/31/20181,149,16467,92734,210132,827N/A
12/31/20171,123,95766,251N/A147,774N/A
9/30/20171,113,71153,527N/A96,422N/A
6/30/20171,076,12449,187N/A58,243N/A
3/31/20171,036,11334,188N/A20,582N/A
12/31/20161,014,96619,831N/A18,756N/A
9/30/2016996,88510,688N/A15,855N/A
6/30/20161,002,59211,074N/A66,398N/A
3/31/2016997,33225,784N/A84,569N/A
12/31/2015996,75738,623N/A74,916N/A
9/30/2015978,60035,386N/A55,691N/A
6/30/2015945,03726,648N/A52,953N/A
3/31/2015925,51124,480N/A55,049N/A
12/31/2014893,95323,811N/A46,607N/A
9/30/2014879,69925,540N/A62,201N/A
6/30/2014866,07236,765N/A43,394N/A
3/31/2014848,55141,186N/A53,178N/A
12/31/2013843,31540,772N/A86,194N/A
9/30/2013816,72442,782N/A104,764N/A
6/30/2013809,34137,165N/A111,034N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if A003090's forecast earnings growth is above the savings rate (2.5%).

Earnings vs Market: Insufficient data to determine if A003090's earnings are forecast to grow faster than the KR market

High Growth Earnings: Insufficient data to determine if A003090's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: A003090's revenue (7.8% per year) is forecast to grow slower than the KR market (10.5% per year).

High Growth Revenue: A003090's revenue (7.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if A003090's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.